Mediwatch-Supply Agreement with NHS

Mediwatch plc ("Mediwatch")

Supply Agreement with NHS

30 January 2012

Mediwatch (AIM:MDW) is pleased to announce that it has been awarded a NHS supply contract for England and Northern Ireland for the supply of urodynamic disposables. The agreement will commence on 1 April 2012 and will run until 31 March 2014. The contract is estimated to be worth £250,000 p.a.

Editors Notes:

Mediwatch plc: Innovative Diagnostic Solutions

Mediwatch is a leader in its field. The Company is continually striving to develop and market faster, simpler and less invasive diagnostic products to save lives and restore quality of life for people with a variety of urological conditions.

Founded in 1995, Mediwatch (http://www.mediwatch.com) has developed a range of point-of-care medical equipment for the diagnosis of urological disorders.

The business focuses its design skills towards diagnostic products that can be used across the medical profession.

Mediwatch has established excellent foundations for continued growth building on the acquisition and integration of a division of Medtronic Inc in 2006, an international distribution network and its research and development programmes.

Update-Graham Fulford Charitable Trust (UK)

The charity goes from strength to strength. Established in late 2004 and working closely together with Kidderminster Prostate Cancer Support Group it has carried out 20745 tests and found 486 cancers to date.

More than £315,000 has been raised which has funded nearly 


16,000 PSA blood tests at a cost of £250,000, 

3 Bladder Scanners at a cost of £21,000 and 

32 Mediwatch Bio Scanners at a cost of £25,600 with more planned in 2012



WELCOME
Welcome to the website of the Graham Fulford Charitable Trust, a charity set up and run by Graham Fulford to reduce suffering from prostate cancer by raising awareness and promoting early diagnosis through PSA testing.

SOME FACTSThere are around 32,000 new cases of Prostate Cancer Diagnosed in the UK each year.

Of those, some 10,000 men lose their lives primarily due to the Cancer having spread outside of the Prostate Gland.

If caught early, Prostate Cancer can be treated with excellent future prognosis for the patient.

• What We Do
• Achievements
• Warwick PSA Test Schedule
• Gallery
• Contact Us
• Useful Links

NEW!
View the new Bioscans in the Community listing where you can locate your nearest contact:

Notice of Final Results & Trading Update

27 January 2012

Mediwatch plc ("Mediwatch" or "Company" or "Group") announces that its final results for the year ended 31 October 2011 will be issued during the week commencing 30 January 2012.

The Group also issues the following trading update in advance of the announcement of the final results:

Mediwatch has maintained its turnover and increased profits and cash flows from operations during the year to 31 October 2011, in spite of Mediwatch's major markets in Europe and the USA suffering from economic turbulence. However, profit before tax for the year ended 31 October 2011 is expected to be £322,000 (unaudited) (2010: £233,000), materially lower than market expectations.

Revenues for the year ended 31 October 2011 are expected to be marginally higher at £10.6m (unaudited) (2010: £10.5m). Unfavourable global economic conditions, together with increased competition in the urodynamic market and delays in commercialising PSAwatch, hampered the Group's ability to increase turnover. In addition, gross margins have come under some pressure in the second half of the year to 31 October 2011 due to increased costs from some suppliers, which the Group was not able to pass on to customers, and increased competition in the urodynamic capital and consumer markets.

However, the re-organisation and cost reduction programme that commenced in Q1 2011 has continued in the second half, including the outsourcing of major elements of the Group's manufacturing and a reduction in fixed overheads. This has lead to further cost savings, although cost cutting in certain research and development projects has encountered delays.

Despite a delay during the year arising from the transfer of manufacturing of the test strip to a new site, PSAwatch is now at an early stage of commercialisation with clinical trials in France to gain reimbursement approval, direct marketing starting in Germany, Hong Kong, Mexico and China, growing sales in the UK private sector and the potential for further co-operation and trials with two international pharmaceutical companies.

The Directors have been encouraged by significant sales growth in developing markets including the Far East and Russia during the period, which provides a platform for future growth.

The Company continues to focus on internal efficiencies and the tight management of its cost base. During 2012 the Board anticipates the conclusion of a number of important research and development projects which are expected to strengthen and update the Group's existing product lines in urodynamics and ultrasound while reducing unit costs. 

January-Music,Film and the Odd Joke Spot

Arab Health (23 - 26 January 2012)

Arab health congress highlights current challenges across GCC                  


DUBAI: Highlighting the current challenges and seeking solutions to tackle the growing public health issues across the GCC, the world’s second largest healthcare conference - Arab Health Congress and Exhibition 2012 - kicked off in Dubai on Monday.

Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai and UAE Minister of Finance and Industry, inaugurated the 37th edition of the four-day congress that runs until Jan.26 at the Dubai International Convention and Exhibition Centre, attracting over 71,900 healthcare professionals and hosting over 3,000 healthcare exhibitors from 70 countries.

Abdul Rahman Mohammad Al Owais, Acting UAE Minister of Health, said, “The Arab Health Congress has grown into the second largest exhibition in the world in the arena of healthcare and medical technology.”

“The congress can create significant impact by raising wide awareness among the residents in the UAE and the region,” he added.

Simon Page, managing director of Arab Health organisers Life Sciences-Informa Exhibitions, said that the conference focuses on the increasing ageing population, heavy burden of diseases including diabetes and outdated healthcare systems.

“The region’s largest healthcare event will assist healthcare experts by providing a platform to facilitate partnerships and future solutions for ageing populations and disease management,” he added.

According to him, the health congress continues to build on its conference portfolio offering a scientific and educational platform that comprises the world’s largest CME (Continuing Medical Education) accredited multi-track series of conferences.

Lisa Stephens, executive director of Informa Exhibitions, elaborated, “The conference has specifically developed a social media arena to allow delegates to communicate and engage in the wider medical community, in recognition of the trend towards greater engagement through social media.”

“Due to the importance of mobile health in the region, experts from the Middle East and internationally are set to gather tomorrow at the leading m+Health Conference,” she added.

The congress showcases new seminars including haematology track at Medlab, biomedical engineering, medical education, m+Health and wound care conferences.

This year’s Arab Health Congress will feature the return of the Middle East Interventional Cardiovascular conference, which will focus on providing delegates with an educational platform to underline the latest updates and improvements in the field of vascular medicine.

Mediwatch Distributor Update-Promedia (Germany)

Link to last update (August 2010) mediwatch-distributor-update-promedia

We are now seeing the first courses being rolled out:

These courses are via Mediwatch distributor Promedia but not sure if Mediwatch products are being used as part of the training.

10/02/2012	Urogynecology Basic Course (2 days) Certification course for the Urogynecology basic training. AGUB I. Basic Qualification Qualification certificate about the technical and scientific expertise in the field of urogynecology and pelvic floor reconstruction for women doctors. AGUB I describes the resident / clinician in the Urogynecology and has trained without a urodynamic test site operates basic diagnostic and therapy in this field. Diagnosis: history, clinical examination of urinary incontinence and prolapse, 100 Urogynecology ultrasonography (nephro-Sono, residual urine, perineal, introitus sonography) Therapy: 50 conservative therapies for stress urinary incontinence 50 conservative therapies for urge incontinence 20 conservative therapies for prolapse Research / Teaching: Urogynecology Course I and II Scientific Director: Dr. med Bernd Fischer, Luneburg Dr. Peter Hess MD-Erdmann, Luneburg Dr. MD Thomas Nosselt, Hamelin Organizer: Institute for training health professionals , Rudolf-Diesel-Straße 3 D-21614 Buxtehude Phone: +49 (0) 4161/669 30 10 Fax: +49 (0) 4161/669 30 20 E-mail: schulung@wfm-ultraschall.de Internet: www.wfm-ultraschall.de Note: Certification by the Medical Council of Lower Saxony and AGUB. Basic and advanced course entitled to acquire the skills level AGUB I. Venue: Hotel Bergström When Luner Muhle 1, Kennedy Space / Washington 21335 Luneburg, Mühleninsel, Tel 04131-3080 Registration / reservations: Please refer to the website www. wfm ultraschall.de- On request, individual training courses on ultrasound performed at your location. Start of the event: Friday 16.00 clock PARTICIPATION FEE: € 300, - (incl. 19% VAT and certification) € 180, - for ace in training discount for members of AGUB: € 25, - Certification AGUB I The applicant must be a specialist and a member of AGUB. The certification can be made ​​if the applicant meets the basic course and advanced course has completed and conservative cases Urogynecology and sonography are presented. On ultrasonography, 100 individual cases must be submitted. In the conservative therapies can a certificate from the instructor (> = AGUB II) samples are available or claimed.
02/11/2012	Urogynecology Basic Course (2 days) Certification course for the Urogynecology basic training. AGUB I. Basic Qualification Qualification certificate about the technical and scientific expertise in the field of urogynecology and pelvic floor reconstruction for women doctors. AGUB I describes the resident / clinician in the Urogynecology and has trained without a urodynamic test site operates basic diagnostic and therapy in this field. Diagnosis: history, clinical examination of urinary incontinence and prolapse, 100 Urogynecology ultrasonography (nephro-Sono, residual urine, perineal, introitus sonography) Therapy: 50 conservative therapies for stress urinary incontinence 50 conservative therapies for urge incontinence 20 conservative therapies for prolapse Research / Teaching: Urogynecology Course I and II Scientific Director: Dr. med Bernd Fischer, Luneburg Dr. Peter Hess MD-Erdmann, Luneburg Dr. MD Thomas Nosselt, Hamelin Organizer: Institute for training health professionals , Rudolf-Diesel-Straße 3 D-21614 Buxtehude Phone: +49 (0) 4161/669 30 10 Fax: +49 (0) 4161/669 30 20 E-mail: schulung@wfm-ultraschall.de Internet: www.wfm-ultraschall.de Note: Certification by the Medical Council of Lower Saxony and AGUB. Basic and advanced course entitled to acquire the skills level AGUB I. Venue: Hotel Bergström When Luner Muhle 1, Kennedy Space / Washington 21335 Luneburg, Mühleninsel, Tel 04131-3080 Registration / reservations: Please refer to the website www. wfm ultraschall.de- On request, individual training courses on ultrasound performed at your location. Start of the event: Friday 16.00 clock PARTICIPATION FEE: € 300, - (incl. 19% VAT and certification) € 180, - for ace in training discount for members of AGUB: € 25, - Certification AGUB I The applicant must be a specialist and a member of AGUB. The certification can be made ​​if the applicant meets the basic course and advanced course has completed and conservative cases Urogynecology and sonography are presented. On ultrasonography, 100 individual cases must be submitted. In the conservative therapies can a certificate from the instructor (> = AGUB II) samples are available or claimed.
08/01/2012	Urogynecology Advanced Course (2 days) Certification course for the Urogynecology basic training. AGUB I. Basic Qualification Qualification certificate about the technical and scientific expertise in the field of urogynecology and pelvic floor reconstruction for women doctors. AGUB I describes the resident / clinician in the Urogynecology and has trained without a urodynamic test site operates basic diagnostic and therapy in this field. Diagnosis: history, clinical examination of urinary incontinence and prolapse, 100 Urogynecology ultrasonography (nephro-Sono, residual urine, perineal, introitus sonography) Therapy: 50 conservative therapies for stress urinary incontinence 50 conservative therapies for urge incontinence 20 conservative therapies for prolapse Research / Teaching: Urogynecology Course I and II Scientific Director: Dr. med Bernd Fischer, Luneburg Dr. Peter Hess MD-Erdmann, Luneburg Dr. MD Thomas Nosselt, Hamelin Organizer: Institute for training health professionals , Rudolf-Diesel-Straße 3 D-21614 Buxtehude Phone: +49 (0) 4161/669 30 10 Fax: +49 (0) 4161/669 30 20 E-mail: schulung@wfm-ultraschall.de Internet: www.wfm-ultraschall.de Note: Certification by the Medical Council of Lower Saxony and AGUB. Basic and advanced course entitled to acquire the skills level AGUB I. Venue: Hotel Bergström When Luner Muhle 1, Kennedy Space / Washington 21335 Luneburg, Mühleninsel, Tel 04131-3080 Registration / reservations: Please refer to the website www. wfm ultraschall.de- On request, individual training courses on ultrasound performed at your location. Start of the event: Friday 08.00 clock PARTICIPATION FEE: € 400, - (incl. 19% VAT and certification) € 260, - for ace in training discount for members of AGUB: € 25, - Certification AGUB I The applicant must be a specialist and a member of AGUB. The certification can be made ​​if the applicant meets the basic course and advanced course has completed and conservative cases Urogynecology and sonography are presented. On ultrasonography, 100 individual cases must be submitted. In the conservative therapies can a certificate from the instructor (> = AGUB II) samples are available or claimed.
01/09/2012	Urogynecology Advanced Course (2 days) Certification course for the Urogynecology basic training. AGUB I. Basic Qualification Qualification certificate about the technical and scientific expertise in the field of urogynecology and pelvic floor reconstruction for women doctors. AGUB I describes the resident / clinician in the Urogynecology and has trained without a urodynamic test site operates basic diagnostic and therapy in this field. Diagnosis: history, clinical examination of urinary incontinence and prolapse, 100 Urogynecology ultrasonography (nephro-Sono, residual urine, perineal, introitus sonography) Therapy: 50 conservative therapies for stress urinary incontinence 50 conservative therapies for urge incontinence 20 conservative therapies for prolapse Research / Teaching: Urogynecology Course I and II Scientific Director: Dr. med Bernd Fischer, Luneburg Dr. Peter Hess MD-Erdmann, Luneburg Dr. MD Thomas Nosselt, Hamelin Organizer: Institute for training health professionals , Rudolf-Diesel-Straße 3 D-21614 Buxtehude Phone: +49 (0) 4161/669 30 10 Fax: +49 (0) 4161/669 30 20 E-mail: schulung@wfm-ultraschall.de Internet: www.wfm-ultraschall.de Note: Certification by the Medical Council of Lower Saxony and AGUB. Basic and advanced course entitled to acquire the skills level AGUB I. Venue: Hotel Bergström When Luner Muhle 1, Kennedy Space / Washington 21335 Luneburg, Mühleninsel, Tel 04131-3080 Registration / reservations: Please refer to the website www. wfm ultraschall.de- On request, individual training courses on ultrasound performed at your location. Start of the event: Friday 08.00 clock PARTICIPATION FEE: € 400, - (incl. 19% VAT and certification) € 260, - for ace in training discount for members of AGUB: € 25, - Certification AGUB I The applicant must be a specialist and a member of AGUB. The certification can be made ​​if the applicant meets the basic course and advanced course has completed and conservative cases Urogynecology and sonography are presented. On ultrasonography, 100 individual cases must be submitted. In the conservative therapies can a certificate from the instructor (> = AGUB II) samples are available or claimed.

Basic and Advanced Courses

A list of distributors can be found under the month of April 2009 under Distributors for Mediwatch Products

Mediwatch Distributor-SPAIN (Instrumentos Científicos,SA)

It's been a while since I've updated or added to the Mediwatch distributors list........Spain,if I remember correctly was rather complicated in that the Mediwatch website refers to Synmed Spain as the main distributor but if you follow it through it displays the old Medtronic equipment so I removed it from the list......and just to confuse things further the Synmed Sweden site does offer a range of Mediwatch products!

Now we have got the history lesson out of the way.............we now have 'Instrumentos Científicos, SA'

Instrumentos Científicos, SA

Mission and Objectives

We must be able to secure our future career, producing intellectual capital to deliver greater value to our activities. Increase our prestige and solvency ratios, and thus win the trust of our clients and collaborators.
It is a main objective of our work to the greatest motivation. Generate based business ethics and knowledge. And to achieve, to the satisfaction of our employees, their effort, their ability to learn and loyalty.

Areas of Application

ICSA, is present in many industrial sectors. And most important in research settings, medicine and universities. Primarily working in all those areas where chemical and biological sciences are a major element in the development process. And most especially, in those environments that require being regulated under Quality Standards, recognized by international organizations competent in these matters.


The Advisory and Consulting Services for the implementation of quality systems or computerized management systems can serve sectors as diverse as Health, Research or the Company, in all areas. And they are especially related to the implementation of Quality Control.


These advanced services, together with powerful tools ERPS and LIMS , enable continuous improvement and strict control of the processes taking maximum advantage of existing resources, without need for highly skilled personnel in information technology.


The Products and Equipment , which provides its clients ICSA are endorsed by renowned international brands that are leaders in technological advances. They have a comprehensive warranty. Service and after sales maintenance for ensuring the profitability of the project undertaken, providing a rapid return on investment.


From this broad perspective, the scope of the ICSA Professional Activities, aim to provide a service to science and a contribution to Analytical Excellence.

Planning for action

Scientific Instruments, Inc. provides services throughout the Spanish territory as well as in Latin America.

(The above is Google translated from their website)

The banner below will take you to their website:

I will update the main page found under the month of April 2009 under Distributors for Mediwatch Products

               

                  

(UK) Manchester City legend Mike Summerbee

 I can't believe I had cancer
January 07, 2012

 Manchester CITY hero Mike Summerbee has spoken about his battle with prostate cancer.

 The 69-year-old was diagnosed after taking a routine test at a health event aimed at persuading other men to check themselves out.


 Now Summerbee, who has undergone surgery and is making an excellent recovery, has thanked his family, the club, and the doctors who helped save his life. The legendary winger had been an at open day at the Alexandra Hospital in Cheadle last summer when medics asked if he wanted to have a PSA test – a simple procedure that can detect prostate cancer. He agreed to show how easy it was and encourage other men to do the same. But the star, who had felt fit and healthy, was stunned when he got his results a week later, revealing there was potentially something wrong.

 After further tests and a biopsy, he was diagnosed with an aggressive but treatable form of prostate cancer. He underwent major surgery to remove the tumour in September and has since been told he is clear of the disease.

Summerbee said: “I’m the type of person that doesn’t like to bother the doctor at all. I’ve always been a fit person, touch wood, being a footballer. I went along to the health day to try to raise awareness of men’s health and I then had a bit of fun with the surgeons. I had my blood pressure checked and it was fine. We did a neck test for potential strokes and that came back clear too. I then had my blood tested - and they called me later to say I had a bit of a problem.

 “I thought there was nothing wrong with me - I never felt ill at all. When I got the news I had prostate cancer and it was aggressive, I was shocked but I didn’t panic. I had no symptoms at all.” Summerbee – one of the stars of the famous City team of the 1960s and 1970s – said his experience had made him value his family more than ever before.

 He said: “When you get something like this, you don't realise how much you need that support and how your wife or partner often has to carry so much of the burden.

 “I’m just glad to be here and I hope to raise awareness of prostate cancer - that‘s why I‘m speaking about it. Men need to go to the doctor’s and ask for the test because prostate cancer really is a hidden killer.” Consultant urologist Andrew Sinclair, from Manchester Urology, was one of the medics who treated Summerbee at the Alexandra - and also helped to organise the health day. He said: “Mike very kindly agreed to help us out and support the event, which was fantastic, but we never expected it would also help to save his life.

 “We found he had significant prostate cancer and it definitely needed to be discovered when it was. His operation was a success and his recovery has gone very well. If anyone is concerned about prostate cancer, they should see their GP to discuss further investigations.” Link to BBC article

PSAwatch developments in the UK and France

This was from the 8 December 2011 but forgot to update here:

PSAwatch developments in the UK and France

RNS Number : 5950T

Mediwatch PLC

08 December 2011

Mediwatch (AIM:MDW) is pleased to announce that PSAwatch continues to make good progress in line with the company strategy. Since moving to a new manufacturing site and obtaining a stable supply of test strips, Mediwatch has actively promoted PSAwatch in the UK and international markets.

In the UK charitable groups are switching to using PSAwatch as a PSA measuring device in well-man prostate awareness meetings. Mediwatch has been working closely with the Graham Fulford Charitable Trust (GFCT) for a number of years and they have transitioned to using PSAwatch as their standard method of PSA testing. Over the past few years, the GFCT (www.grahamfulford.org.uk) has raised over £275,000 and conducted over 20,000 free PSA tests across the UK, leading to the early diagnosis of nearly 500 prostate cancers to date.

In France, a clinical study which involved testing over 200 men has been carried out over the course of 2011 comparing PSAwatch to laboratory PSA values. The study, which was led by one of France's leading urologists, has been conducted at six locations across the country and five sites have now completed with the remaining hospital expected to finish patient testing before the end of 2011.

Based on the results from the first five sites, AVF Biomédical (SAS), Mediwatch's distributor in France, has launched the PSAwatch system at the Annual French Urology (AFU) congress in Paris which was held between 16^th and 19^th November 2011and they have already received orders. It is estimated that around 6 million PSA tests are conducted in France each year, for assisting both diagnosis and surveillance of prostate disease.

Mediwatch has begun direct marketing of PSAwatch into Europe, Middle East, Asia Pacific and Latin America. A large clinical trial is scheduled to begin at the Royal Hospital in Melbourne in Australia in early 2012. In addition, Mediwatch are looking into increasing the utility of the reader into other applications. These are very positive developments for the product line which management expects will see increasing revenues and exposure.

Enquiries

Mediwatch plc

Tel: +44 (0)1788 547 888

Philip Stimpson, Chief Executive

Fairfax I.S. PLC

Tel: +44 (0)20 7598 5368

Ewan Leggat / Laura Littley

Editors Notes:

Mediwatch plc: Innovative Diagnostic Solutions

Mediwatch is a leader in its field. The Company is continually striving to develop and market faster, simpler and less invasive diagnostic products to save lives and restore quality of life for people with a variety of urological conditions. Founded in 1995, Mediwatch (http://www.mediwatch.com) has developed a range of point-of-care medical equipment for the diagnosis of urological disorders.

The business focuses its design skills towards diagnostic products that can be used across the medical profession.

Mediwatch has established excellent foundations for continued growth building on the acquisition and integration of a division of Medtronic Inc in 2006, an international distribution network and its research and development programmes.

This information is provided by RNS

The company news service from the London Stock Exchange

LATEST NEWS AND FUTURE EVENTS

Latest News/Website Updates





Renal And Urology News-December 2011 Edition


Urology Times-November 2011 Edition



Mediwatch Positions/Jobs


Mediwatch/Distributor Training Courses

Germany

These courses are via Mediwatch distributor Promedia but not sure if Mediwatch products are being used as part of the training.

10/02/2012 Urogynecology Basic Course (2 days)
02/11/2012 Urogynecology Basic Course (2 days)
08/01/2012 Urogynecology Advanced Course (2 days)
01/09/2012 Urogynecology Advanced Course (2 days)
Basic and Advanced Courses

USA
Three new workshops announced for 2012:
Urodynamics Workshop WPB Date 11,12 Feb 2012 Deadline 27 Jan
ARM Workshop Boston Date 13th Apr 2012 Deadline 23rd Mar
Urodynamics Workshop WPB Date 13,14 Oct 2012 Deadline 28 Sep



Future Events Events where Mediwatch are attending/exhibiting will be marked as so or updated,hopefully before the event is finished.More Events to add later

45th Annual Conference of the Urological Society of India 5th-8th January 2012
Active Surveillance for Low Risk Prostate Cancer-Netherlands 12th-13th January
Dubai International Convention & Exhibition Centre 23rd-26th January 2012 Mediwatch are Exhibiting in Hall 7-Stand 7F30


STUFF THAT MAYBE DID BUT NOW DOESN'T FIT IN WITH THE TITLE...

Staffordshire University Honorary Doctors 2011-Philip Stimpson-July 2011

Directors' Shareholdings-Issued 28th July

Interim Results for the six months to 30 April 2011-This copy 28th July (RNS-26th July)

Mediwatch-Annual Report-Issued 24th March 2011

Mediwatch-Final Results for year ended 31 October 2010-Issued 27th January 2011

Mediwatch USA Inc. Awarded US General Service Administration Federal Supply Schedule Contract 14th December

OEM Partnership with ACON Laboratories 1st November

Website Update (Aug)-Mobile Watch

Interim Results

Mediwatch Newsletter-July 2010 Edition

OEM Partnership with Thought Technology Ltd Mediwatch-14th June

Distribution Agreement with GE Healthcare Mediwatch-8th June